Hormone therapy and affect
- PMID: 399315
- DOI: 10.1016/0378-5122(79)90015-x
Hormone therapy and affect
Abstract
This study investigated the influence of hormone therapy on affect in a double blind crossover trail. The sample consisted of 49 women who had previously undergone hysterectomy and bilateral oophorectomy. Therapy consisted of 3 mth each of ethynyl oestradiol-50 micron/day, levonorgestrel-250 micron/day, "Nordial"-a combination of these two substances, and placebo. Affect was measured by the Hamilton Depression Rating Scale, verbal reports by women and self-ratings on visual analogue scales. Ethinyl oestradiol was found to have a beneficial influence on aspects of affect such as Hamilton scores, anxiety irritability and insomnia. The influence of hormones on Hamilton scores could be partly but not fully explained by the alleviation of hot flushes. Norgestrel showed less favourable changes initially but these tended to diminish by the third therapy month. Most of the women studied were not clinically depressed. Anxiety symptoms were the major features exhibited in the group of women investigated. The results of this study suggest that visual analogue rating scales are of questionable validity in assessing affect in patients without any appreciable psychiatric morbidity.
PIP: This study investigated the influence of hormone therapy on affect in a double blind crossover trial. The sample consisted of 49 women who had previously undergone hysterectomy and bilateral oophorectomy. Therapy consisted of 3 mth each of ethinyl estradiol--50 mcg/day; levonorgestrel--250 mcg/day; "Nordial"--a combination of these 2 substances; and placebo. Affect was measured by the Hamilton Depression Rating Scale, verbal reports by women and self-ratings on visual analogue scales. Ethinyl estradiol was found to have a beneficial influence on aspects of affect such as Hamilton scores, anxiety, irritability, and insomnia. The influence of hormones on Hamilton scores could be partly but not fully explained by the alleviation of hot flushes. Norgestrel showed less favorable changes initially but these tended to diminish by the 3rd therapy month. Most of the women studied were not clinically depressed. Anxiety symptoms were the major features exhibited in the group of women investigated. The results of this study suggest that visual analogue rating scales are of questionable validity in assessing affect in patients without any appreciable psychiatric morbidity.
Similar articles
-
Plasma levels of ethinyl oestradiol and norgestrel during hormone replacement therapy.Maturitas. 1980 Jul;2(2):147-54. doi: 10.1016/0378-5122(80)90049-3. Maturitas. 1980. PMID: 7207216
-
Hormone replacement therapy and sexuality in women.Clin Endocrinol Metab. 1982 Nov;11(3):661-79. doi: 10.1016/s0300-595x(82)80006-6. Clin Endocrinol Metab. 1982. PMID: 6814799
-
Comparison of contraceptive acceptability of levonorgestrel and ethinyl oestradiol administered in one three-phasic (Trionetta) and one monophasic (Neovletta) version.Contraception. 1983 May;27(5):439-52. doi: 10.1016/0010-7824(83)90041-0. Contraception. 1983. PMID: 6349925 Clinical Trial.
-
Emergency contraception: a review.Contraception. 1994 Aug;50(2):101-8. doi: 10.1016/0010-7824(94)90046-9. Contraception. 1994. PMID: 7956209 Review.
-
Norgestimate: a clinical overview of a new progestin.Am J Obstet Gynecol. 1992 Jun;166(6 Pt 2):1969-77. doi: 10.1016/0002-9378(92)91397-s. Am J Obstet Gynecol. 1992. PMID: 1605287 Review.
Cited by
-
Initiation and discontinuation of hormone therapy for menopausal symptoms: results from a community sample.J Behav Med. 2005 Feb;28(1):105-14. doi: 10.1007/s10865-005-2721-2. J Behav Med. 2005. PMID: 15887880
-
Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes.Cochrane Database Syst Rev. 2004 Oct 18;2004(4):CD002978. doi: 10.1002/14651858.CD002978.pub2. Cochrane Database Syst Rev. 2004. PMID: 15495039 Free PMC article.
-
Double-blind, placebo-controlled, hormonal, syndromal and EEG mapping studies with transdermal oestradiol therapy in menopausal depression.Psychopharmacology (Berl). 1995 Dec;122(4):321-9. doi: 10.1007/BF02246261. Psychopharmacology (Berl). 1995. PMID: 8657828 Clinical Trial.
-
Monophasic estrogen-progestogen therapy and sexuality in postmenopausal women.Clin Drug Investig. 2007;27(2):131-7. doi: 10.2165/00044011-200727020-00006. Clin Drug Investig. 2007. PMID: 17217318 Clinical Trial.
-
Should symptomatic menopausal women be offered hormone therapy?MedGenMed. 2006;8(3):40. MedGenMed. 2006. PMID: 17410686 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources